292 related articles for article (PubMed ID: 2981427)
1. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.
Sodroski J; Rosen C; Wong-Staal F; Salahuddin SZ; Popovic M; Arya S; Gallo RC; Haseltine WA
Science; 1985 Jan; 227(4683):171-3. PubMed ID: 2981427
[TBL] [Abstract][Full Text] [Related]
2. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor.
Fujisawa J; Seiki M; Kiyokawa T; Yoshida M
Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2277-81. PubMed ID: 2986109
[TBL] [Abstract][Full Text] [Related]
3. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.
Rosen CA; Sodroski JG; Haseltine WA
Cell; 1985 Jul; 41(3):813-23. PubMed ID: 2988790
[TBL] [Abstract][Full Text] [Related]
4. Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors.
Rosen CA; Sodroski JG; Kettman R; Haseltine WA
J Virol; 1986 Mar; 57(3):738-44. PubMed ID: 3005624
[TBL] [Abstract][Full Text] [Related]
5. Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription.
Shimotohno K; Takano M; Teruuchi T; Miwa M
Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8112-6. PubMed ID: 3022280
[TBL] [Abstract][Full Text] [Related]
6. A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I.
Fujisawa J; Seiki M; Sato M; Yoshida M
EMBO J; 1986 Apr; 5(4):713-8. PubMed ID: 3011423
[TBL] [Abstract][Full Text] [Related]
7. cis- and trans-acting transcriptional regulation of visna virus.
Hess JL; Clements JE; Narayan O
Science; 1985 Aug; 229(4712):482-5. PubMed ID: 2990051
[TBL] [Abstract][Full Text] [Related]
8. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
Derse D; Casey JW
Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
[TBL] [Abstract][Full Text] [Related]
9. Characterization of long terminal repeat sequences of HTLV-III.
Starcich B; Ratner L; Josephs SF; Okamoto T; Gallo RC; Wong-Staal F
Science; 1985 Feb; 227(4686):538-40. PubMed ID: 2981438
[TBL] [Abstract][Full Text] [Related]
10. Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity.
Seigel LJ; Ratner L; Josephs SF; Derse D; Feinberg MB; Reyes GR; O'Brien SJ; Wong-Staal F
Virology; 1986 Jan; 148(1):226-31. PubMed ID: 3002031
[TBL] [Abstract][Full Text] [Related]
11. The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat.
Katoh I; Yoshinaka Y; Sagata N; Ikawa Y
Jpn J Cancer Res; 1987 Feb; 78(2):93-8. PubMed ID: 3030987
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of human T-lymphotropic retroviruses.
Wong-Staal F; Ratner L; Shaw G; Hahn B; Harper M; Franchini G; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4539s-4544s. PubMed ID: 2990683
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the trans-activation capabilities of the human T-cell leukemia virus type I and II chi proteins.
Shah NP; Wachsman W; Cann AJ; Souza L; Slamon DJ; Chen IS
Mol Cell Biol; 1986 Nov; 6(11):3626-31. PubMed ID: 3025604
[TBL] [Abstract][Full Text] [Related]
14. Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes.
Rosen CA; Sodroski JG; Campbell K; Haseltine WA
J Virol; 1986 Jan; 57(1):379-84. PubMed ID: 3001360
[TBL] [Abstract][Full Text] [Related]
15. Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III.
Rosen CA; Sodroski JG; Goh WC; Dayton AI; Lippke J; Haseltine WA
Nature; 1986 Feb 13-19; 319(6054):555-9. PubMed ID: 3003584
[TBL] [Abstract][Full Text] [Related]
16. Repetitive structure in the long-terminal-repeat element of a type II human T-cell leukemia virus.
Sodroski J; Trus M; Perkins D; Patarca R; Wong-Staal F; Gelmann E; Gallo R; Haseltine WA
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4617-21. PubMed ID: 6087335
[TBL] [Abstract][Full Text] [Related]
17. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I.
Siekevitz M; Feinberg MB; Holbrook N; Wong-Staal F; Greene WC
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5389-93. PubMed ID: 3037548
[TBL] [Abstract][Full Text] [Related]
18. Long terminal repeats of human T-cell leukaemia virus II genome determine target cell specificity.
Chen IS; McLaughlin J; Golde DW
Nature; 1984 May 17-23; 309(5965):276-9. PubMed ID: 6325950
[TBL] [Abstract][Full Text] [Related]
19. Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat.
Rosen CA; Sodroski JG; Haseltine WA
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6502-6. PubMed ID: 2995968
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell growth factor (interleukin 2) and gamma-interferon genes: expression in human T-lymphotropic virus type III- and type I-infected cells.
Arya SK; Gallo RC
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8691-5. PubMed ID: 3001715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
